Ileitis: Clinical Trials

4 trials for Ileitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow Ileitis: new trials by email Literature Review of Ileitis trials Research Report on Ileitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stelara fOr ChRonic AntibioTic rEfractory pouchitiS
Ustekinumab - Pouchitis
Phase 3CompletedUniversitaire Ziekenhuizen KU Leuven202020-06-152024-12-11
Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of Antibiotics
Alicaforsen, Placebo - Pouchitis
Phase 3CompletedAtlantic Pharmaceuticals Ltd1382015-12-032020-02-25
Adalimumab in the Treatment of Chronic Pouchitis
Adalimumab, Placebo - Ulcerative Colitis, Pouchitis
Phase 3CompletedOdense University Hospital132012-08-012016-01-28
Clinical Approaches to Ileal Pouch Dysfunction
Electronic Barostat - Pouchitis
Phase 3CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)642010-03-18

Narrower conditions

Pouchitis (4)  ·  Colitis, Ulcerative (1)

Broader conditions

Digestive System Diseases (4)  ·  Enteritis (4)  ·  Gastroenteritis (4)  ·  Gastrointestinal Diseases (4)  ·  Ileal Diseases (4)  ·  Intestinal Diseases (4)  ·  Colitis (1)  ·  Colonic Diseases (1)  ·  Inflammatory Bowel Diseases (1)

Interventions

Adalimumab (1)  ·  Ustekinumab (1)  ·  alicaforsen (1)

Sponsors

Atlantic Pharmaceuticals Ltd (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Odense University Hospital (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)

Countries

Belgium (2)  ·  United States (2)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Bo Shen, M.D. (1)  ·  Chris Dunk (1)  ·  Jens Kjeldsen, Phd (1)  ·  Marc Ferrante, MD, PhD (1)

Results publications

PMID 38750870

NIH funding

R03DK067275 (1)